Yield10 Bioscience Inc
YTEN
Get informed when a big investor buys or sells
+ FollowMarket Cap$345.46K
Close$
$-0.29
185.2% downside
Current Fair Value
185.2% downsideOvervalued by 185.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $345,460.00 |
|---|---|
| Enterprise Value | $3.18 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-43.66 |
| Beta | 1.43 |
| Outstanding Shares | 642,444 |
Return
| Return on Equity | 203.62% |
|---|---|
| Return on Assets | -427.96% |
| Return on Invested Capital | 270.81% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.06 |
| Price to Sales | 0.34 |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | 3.92 |
| Enterprise Value to EBIT | -0.25 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.12 |
| Debt to Equity | -0.57 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Yield10 Bioscience Inc
CEO: Oliver Peoples Yield10 Bioscience, Inc. is an agricultural bioscience company developing crop innovations aligned with trends in global food security, social responsibility, and sustainability. The Company is using its 'Trait Factory,' a differentiated...